Deciphera Pharmaceuticals financials at a glance

+ Portfolio

The revenue of Deciphera Pharmaceuticals is reported as 0.16336 billion Dollars in the fiscal year 2023. The earnings were -2.29 Dollars per share in 2023, which was 3.38 higher than 2022. And about -0.14748 billion Dollars are reported as free cash flow in the financials of Deciphera Pharmaceuticals 2023. No dividends were paid to the shareholders of the Deciphera Pharmaceuticals stock NasdaqGS:DCPH in the financial year 2023.

$163.36M

Revenue

$-2.29

Earnings Per Share

-45.61%

Gross Margin %

$-,175.78M

Free Cash Flow

Revenue

163.36

Earnings Per Share

-2.29

Gross Margin %

-45.61

Free Cash Flow

-,175.78

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017
Rev.	Revenue	N/A	$163.36M	$134.04M	$96.15M	$42.09M	$25.00M	$0.00M	$0.00M
GM %	Gross Margin %	-51.10%	-45.61%	-46.67%	-,147.30%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	-,136.64%	-,129.14%	-,136.32%	-,284.85%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-2.30	$-2.29	$-2.37	$-5.16	$-4.78	$-4.48	$-2.82	$-2.99
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	80.8M	75.95M	58.55M	57.63M	55.65M	38.19M	32.59M
OCF	Operating Cash Flow	N/A	$-,146.70M	$-,152.86M	$-,240.82M	$-,239.68M	$-,149.30M	$-86.78M	$-36.70M
FCF	Free Cash Flow	N/A	$-,175.78M	$-,153.70M	$-,242.79M	$-,245.00M	$-,154.23M	$-87.91M	$-37.11M
FCFS	Free Cash Flow Per Share	$-1.83	$-1.73	$-2.04	$-4.25	$-4.39	$-3.60	$-2.48	$-2.21

Deciphera Pharmaceuticals financials at a glance

Financials

Discover